The project builds on decades of research at the Sieweke Lab @siewekelab.bsky.social and combines it with cell production expertise of Dr. Anke Fuchs.
New research group at the CRTD @tudresden.bsky.social !🎉🔬
Supported by the ERC Starting Grant, Dr. Anna Czarkwiani @aniaczark.bsky.social is launching a new group to study the sense of gravity and #regeneration in the inner ear in axolotl.
Read more ➡️ tud.link/buva24
#CMCBnews
Im Rahmen der Studie Fr1da: „Typ-1-Diabetes früh erkennen, früh gut behandeln“ vom @crtd-tud.bsky.social & dem Universitätsklinikum Dresden können Familien ihre Kinder im Alter von zwei bis zehn Jahren auf ein Frühstadium von Typ-1-Diabetes testen lassen. 🧸 #Diabetes
ℹ️ tu-dresden.de/tu-dresden/n...
Prof. Albert @mareikealbert.bsky.social is part of MICRO-NEST, a new international consortium. Backed by €6 million Horizon Europe grant 🇪🇺, it combines multidisciplinary expertise to study early markers of autism spectrum disorders.
Read more ➡️ tud.link/319gn4
#CMCBnews @tudresden.bsky.social
“Super macrophages” against cancer 🧬
Prof. Michael Sieweke, Dr. Anke Fuchs, and Dr. Angela Jacobi are developing a new immune cell therapy targeting solid tumors. Backed by €2.5M from the EIC, StemPhage aims to bring this approach closer to clinical use 🔬
Read more ➡️ tud.link/vwwmxg
#CMCBnews